Cholesterol oxidation products and their biological importance

Chemistry and Physics of Lipids

Volumn 199, Issue , 2016, Pages 144-160

  Kulig, Waldemar ^a,b   Cwiklik, Lukasz ^c,d   Jurkiewicz, Piotr ^c   Rog, Tomasz ^a,b   Vattulainen, Ilpo ^a,b,e  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c J HEYROVSKÝ INSTITUTE OF PHYSICAL CHEMISTRY   (Czech Republic)

^d INSTITUTE OF MATHEMATICS   (Czech Republic)

^e UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Biological membranes; Biophysical properties; Cholesterol; Oxidation; Oxidative stress; Oxysterols; Reactive oxygen species

Indexed keywords

CHOLESTEROL; DETERGENT; OXYSTEROL; LIPID BILAYER;

ARTICLE; ATHEROSCLEROSIS; BIOLOGICAL FUNCTIONS; DEGENERATIVE DISEASE; ENZYME SYNTHESIS; EYE DISEASE; HUMAN; INFLAMMATION; LIPID BILAYER; LIPID MEMBRANE; LIPOGENESIS; NEOPLASM; OXIDATION; PHOSPHOLIPID BILAYER; PRIORITY JOURNAL; ANIMAL; DISEASES; METABOLISM; OXIDATION REDUCTION REACTION;

ANIMALS; CHOLESTEROL; DISEASE; HUMANS; LIPID BILAYERS; OXIDATION-REDUCTION; OXYSTEROLS;

EID: 84959894259     PISSN: 00093084     EISSN: 18732941     Source Type: Journal    
DOI: 10.1016/j.chemphyslip.2016.03.001     Document Type: Article

References (279)

1. Abildayeva, K., Jansen, P.J., Hirsch-Reinshagen, V., Bloks, V.W., Bakker, A.H.F., Ramaekers, F.C.S., de Vente, J., Groen, A.K., Wellington, C.L., Kuipers, F., Mulder, M., 24(S)-hydroxycholesterol participates in a liver X receptor-controlled pathway in astrocytes that regulates apolipoprotein E-mediated cholesterol efflux. J. Biol. Chem. 281 (2006), 12799–12808.
2. Aghaloo, T.L., Amantea, C.M., Cowan, C.M., Richardson, J.A., Wu, B.M., Parhami, F., Tetradis, S., Oxysterols enhance osteoblast differentiation in vitro and bone healing in vivo. J. Orthop. Res. 25 (2007), 1488–1497.
3. Ahyayauch, H., Larijani, B., Alonso, A., Goni, F.M., Detergent solubilization of phosphatidylcholine bilayers in the fluid state: influence of the acyl chain structure. Biochim. Et Biophys. Acta-Biomembr. 1758 (2006), 190–196.
4. Aittoniemi, J., Rog, T., Niemela, P., Pasenkiewicz-Gierula, M., Karttunen, M., Vattulainen, I., Tilt: major factor in sterols’ ordering capability in membranes. J. Phys. Chem. B 110 (2006), 25562–25564.
5. Anggakusuma, Romero-Brey, I., Berger, C., Colpitts, C.C., Boldanova, T., Engelmann, M., Todt, D., Perin, P.M., Behrendt, P., Vondran, F.W.R., Xu, S.T., Goffinet, C., Schang, L.M., Heim, M.H., Bartenschlager, R., Pietschmann, T., Steinmann, E., Interferon-inducible cholesterol-25-hydroxylase restricts hepatitis C virus replication through blockage of membranous web formation. Hepatology 62 (2015), 702–714.
6. Appelqvist, L., Dutta, P., Lidbeck, A., Jameson, S., Reduction of polyunsaturated fatty acid-and cholesterol-oxidation in diabetics supplemented with antioxidants, Oxygen-95. The Annual Meeting of the Oxygen Society, The Oxygen Society, San Francisco, CA, 1995.
7. Ares, M.P.S., Pörn-Ares, M.I., Moses, S., Thyberg, J., Juntti-Berggren, L., Berggren, P.O., Hultgårdh-Nilsson, A., Kallin, B., Nilsson, J., 7β-Hydroxycholesterol induces Ca2+ oscillations, MAP kinase activation and apoptosis in human aortic smooth muscle cells. Atherosclerosis 153 (2000), 23–35.
8. Aupeix, K., Weltin, D., Mejia, J.E., Christ, M., Marchal, J., Freyssinet, J.-M., Bischoff, P., Oxysterol-induced apoptosis in human monocytic cell lines. Immunobiology 194 (1995), 415–428.
9. Babiker, A., Diczfalusy, U., Transport of side-chain oxidized oxysterols in the human circulation. Biochim. Et Biophys. Acta-Lipids Lipid Metab. 1392 (1998), 333–339.
10. Bach, D., Epand, R.F., Epand, R.M., Wachtel, E., Interaction of 7-ketocholesterol with two major components of the inner leaflet of the plasma membrane: phosphatidylethanolamine and phosphatidylserine. Biochemistry 47 (2008), 3004–3012.
11. Bach, D., Epand, R.F., Epand, R.M., Miller, I.R., Wachtel, E., The oxidized form of cholesterol 3 beta-hydroxy-5-oxo-5,6-secocholestan-6-al induces structural and thermotropic changes in phospholipid membranes. Chem. Phys. Lipids 161 (2009), 95–102.
12. Bach, D., Epand, R.F., Epand, R.M., Miller, I.R., Wachtel, E., The oxysterol 3 beta-hydroxy-5-oxo-5,6-secocholestan-6-al changes the phase behavior and structure of phosphatidylethanolamine-phosphatidylcholine mixtures. Chem. Phys. Lipids 164 (2011), 672–679.
13. Bach, D., Wachtel, E., Miller, I.R., Modulation of the kinetics of 3 beta-hydroxy-5-oxo-5,6-secocholestan-6-al/phosphatidylethanolamine Schiff base formation by cholesterol and cholesterol crystallization. Chem. Phys. Lipids 186 (2015), 45–50.
14. Bacia, K., Schwille, P., Kurzchalia, T., Sterol structure determines the separation of phases and the curvature of the liquid-ordered phase in model membranes. Proc. Natl. Acad. Sci. U. S. A. 102 (2005), 3272–3277.
15. Beattie, M.E., Veatch, S.L., Stottrup, B.L., Keller, S.L., Sterol structure determines miscibility versus melting transitions in lipid vesicles. Biophys. J. 89 (2005), 1760–1768.
16. Benga, G., Hodarnau, A., Ionescu, M., Pop, V.I., Frangopol, P.T., Strujan, V., Holmes, R.P., Kummerow, F.A., A comparison of the effects of cholesterol and 25-hydroxycholesterol on egg-yolk lecithin liposomes—spin label studies. Ann. N. Y. Acad. Sci. 414 (1983), 140–152.
17. Berkowitz, M.L., Detailed molecular dynamics simulations of model biological membranes containing cholesterol. Biochim. Et Biophys. Acta-Biomembr. 1788 (2009), 86–96.
18. Berthier, A., Lemaire-Ewing, S., Prunet, C., Monier, S., Athias, A., Bessede, G., de Barros, J.P.P., Laubriet, A., Gambert, P., Lizard, G., Neel, D., Involvement of a calcium-dependent dephosphorylation of BAD associated with the localization of Trpc-1 within lipid rafts in 7-ketocholesterol-induced THP-1 cell apoptosis. Cell Death Differ. 11 (2004), 897–905.
19. Biasi, F., Leonarduzzi, G., Vizio, B., Zanetti, D., Sevanian, A., Sottero, B., Verde, V., Zingaro, B., Chiarpotto, E., Poli, G., Oxysterol mixtures prevent proapoptotic effects of 7-Ketocholesterol in macrophages: implications for proatherogenic gene modulation. FASEB J., 18, 2004, 693.
20. Björkhem, I., Rediscovery of cerebrosterol. Lipids 42 (2007), 5–14.
21. Bjorkhem, I., Diczfalusy, U., Oxysterols—Friends, foes, or just fellow passengers?. Arteriosclerosis Thrombosis Vascular Biol. 22 (2002), 734–742.
22. Bjorkhem, I., Eggertsen, G., Genes involved in initial steps of bile acid synthesis. Curr. Opin. Lipidol. 12 (2001), 97–103.
23. Bjorkhem, I., Lutjohann, D., Diczfalusy, U., Stahle, L., Ahlborg, G., Wahren, J., Cholesterol homeostasis in human brain: turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation. J. Lipid Res. 39 (1998), 1594–1600.
24. Bjorkhem, I., Cedazo-Minguez, A., Leoni, V., Meaney, S., Oxysterols and neurodegenerative diseases. Mol. Aspects Med. 30 (2009), 171–179.
25. Bjorkhem, I., Lovgren-Sandblom, A., Leoni, V., Meaney, S., Brodin, L., Salveson, L., Winge, K., Palhagen, S., Svenningsson, P., Oxysterols and Parkinson's disease: evidence that levels of 24S-hydroxycholesterol in cerebrospinal fluid correlates with the duration of the disease. Neurosci. Lett. 555 (2013), 102–105.
26. Bjorkhem, I., Do oxysterols control cholesterol homeostasis?. J. Clin. Invest. 110 (2002), 725–730.
27. Bjorkhem, I., Crossing the barrier: oxysterols as cholesterol transporters and metabolic modulators in the brain. J. Intern. Med. 260 (2006), 493–508.
28. Blennow, K., de Leon, M.J., Zetterberg, H., Alzheimer's disease. Lancet 368 (2006), 387–403.
29. Bodin, K., Andersson, U., Rystedt, E., Ellis, E., Norlin, M., Pikuleva, I., Eggertsen, G., Bjorkhem, I., Diczfalusy, U., Metabolism of 4 beta-hydroxycholesterol in humans. J. Biol. Chem. 277 (2002), 31534–31540.
30. Boissonneault, G.A., Heiniger, H.J., 25-Hydroxycholesterol-induced elevations in ca-45 uptake—permeability changes in P815-cells. J. Cell. Physiol. 125 (1985), 471–475.
31. Bosco, D.A., Fowler, D.M., Zhang, Q., Nieva, J., Powers, E.T., Wentworth, P. Jr., Lerner, R.A., Kelly, J.W., Elevated levels of oxidized cholesterol metabolites in Lewy body disease brains accelerate alpha-synuclein fibrilization. Nat. Chem. Biol. 2 (2006), 249–253.
32. Boselli, E., Rodriguez-Estrada, M.T., Fedrizzi, G., Caboni, M.F., Cholesterol photosensitised oxidation of beef meat under standard and modified atmosphere at retail conditions. Meat Sci. 81 (2009), 224–229.
33. Bretillon, L., Diczfalusy, U., Bjoerkhem, I., Maire, M.A., Martine, L., Joffre, C., Acar, N., Bron, A., Creuzot-Garcher, C., Cholesterol-24S-hydroxylase (CYP46A1) is specifically expressed in neurons of the neural retina. Curr. Eye Res. 32 (2007), 361–366.
34. Breuer, O., Bjorkhem, I., Simultaneous quantification of several cholesterol autoxidation and monohydroxylation products by isotope-dilution mass-spectrometry. Steroids 55 (1990), 185–192.
35. Breuer, O., Bjorkhem, I., Use of an O-18(2) inhalation technique and mass isotopomer distribution analysis to study oxygenation of cholesterol in rat—evidence for in-vivo formation of 7-oxocholesterol, 7-beta-hydroxycholesterol, 24-hydroxycholesterol, and 24-hydroxycholesterol. J. Biol. Chem. 270 (1995), 20278–20284.
36. Breuer, O., Identification and quantitation of cholest-5-ene-3-beta,4-beta-diol in rat-liver and human plasma. J. Lipid Res. 36 (1995), 2275–2281.
37. Brown, A.J., Jessup, W., Oxysterols and atherosclerosis. Atherosclerosis 142 (1999), 1–28.
38. Brown, A.J., Jessup, W., Oxysterols: sources, cellular storage and metabolism, and new insights into their roles in cholesterol homeostasis. Mol. Aspects Med. 30 (2009), 111–122.
39. Brown, D.A., London, E., Structure of detergent-resistant membrane domains: does phase separation occur in biological membranes?. Biochem. Biophys. Res. Commun. 240 (1997), 1–7.
40. Brown, A.J., Dean, R.T., Jessup, W., Free and esterified oxysterol: formation during copper-oxidation of low density lipoprotein and uptake by macrophages. J. Lipid Res. 37 (1996), 320–335.
41. Brown, A.J., Leong, S.L., Dean, R.T., Jessup, W., 7-Hydroperoxycholesterol and its products in oxidized low density lipoprotein and human atherosclerotic plaque. J. Lipid Res. 38 (1997), 1730–1745.
42. Brown, A.J., Mander, E.L., Gelissen, I.C., Kritharides, L., Dean, R.T., Jessup, W., Cholesterol and oxysterol metabolism and subcellular distribution in macrophage foam cells: accumulation of oxidized esters in lysosomes. J. Lipid Res. 41 (2000), 226–236.
43. Brown, A.J., Watts, G.F., Burnett, J.R., Dean, R.T., Jessup, W., Sterol 27-hydroxylase acts on 7-Ketocholesterol in human atherosclerotic lesions and macrophages in culture. J. Biol. Chem. 275 (2000), 27627–27633.
44. Burlot, M.A., Braudeau, J., Michaelsen-Preusse, K., Potier, B., Ayciriex, S., Varin, J., Gautier, B., Djelti, F., Audrain, M., Dauphinot, L., Fernandez-Gomez, F.J., Caillierez, R., Laprevote, O., Bieche, I., Auzeil, N., Potier, M.C., Dutar, P., Korte, M., Buee, L., Blum, D., Cartier, N., Cholesterol 24-hydroxylase defect is implicated in memory impairments associated with Alzheimer-like Tau pathology. Hum. Mol. Genet. 24 (2015), 5965–5976.
45. Carpenter, K.L.H., Taylor, S.E., Ballantine, J.A., Fussell, B., Halliwell, B., Mitchinson, M.J., Lipids and oxidised lipids in human atheroma and normal aorta. Biochimica et Biophysica Acta (BBA) Lipids and Lipid Metabolism 1167 (1993), 121–130.
46. Carpenter, K.L.H., Taylor, S.E., van der Veen, C., Williamson, B.K., Ballantine, J.A., Mitchinson, M.J., Lipids and oxidised lipids in human atherosclerotic lesions at different stages of development. Biochimica et Biophysica Acta (BBA) Lipids and Lipid Metabolism 1256 (1995), 141–150.
47. Carpenter, K.L.H., Good COP, Bad COP: an unsolved murder. Are dietary cholesterol oxidation products guilty of atherogenicity?. Br. J. Nutr. 88 (2002), 335–338.
48. Chalmin, F., Rochemont, V., Lippens, C., Clottu, A., Sailer, A.W., Merkler, D., Hugues, S., Pot, C., Oxysterols regulate encephalitogenic CD4(+) T cell trafficking during central nervous system autoimmunity. J. Autoimmun. 56 (2015), 45–55.
49. Charbonneau, C., Fournier, I., Dufresne, S., Barwicz, J., Tancrede, P., The interactions of amphotericin B with various sterols in relation to its possible use in anticancer therapy. Biophys. Chem. 91 (2001), 125–133.
50. Chen, J.H., Peng, D.Q., Is 25-hydroxycholesterol the interplay of statins and inflammation?. Int. J. Cardiol. 184 (2015), 255–256.
51. Chen, J.J., Lukyanenko, Y., Hutson, J.C., 25-Hydroxycholesterol is produced by testicular macrophages during the early postnatal period and influences differentiation of leydig cells in vitro. Biol. Reprod. 66 (2002), 1336–1341.
52. Chen, W., Chen, G., Head, D.L., Mangelsdorf, D.J., Russell, D.W., Enzymatic reduction of oxysterols impairs LXR signaling in cultured cells and the livers of mice. Cell Metab. 5 (2007), 73–79.
53. Chiang, J.Y.L., Regulation of bile acid synthesis: pathways, nuclear receptors, and mechanisms. J. Hepatol. 40 (2004), 539–551.
54. Chisolm, G.M., Steinberg, D., The oxidative modification hypothesis of atherogenesis: an overview. Free Radic. Biol. Med. 28 (2000), 1815–1826.
55. Civra, A., Cagno, V., Donalisio, M., Biasi, F., Leonarduzzi, G., Poli, G., Lembo, D., Inhibition of pathogenic non-enveloped viruses by 25-hydroxycholesterol and 27-hydroxycholesterol. Sci. Rep., 4, 2014, 7487.
56. Coppola, S., Ghibelli, L., GSH extrusion and the mitochondrial pathway of apoptotic signalling. Biochem. Soc. Trans. 28 (2000), 56–61.
57. Coskun, U., Simons, K., Cell membranes: the lipid perspective. Structure 19 (2011), 1543–1548.
58. Cunningham, B.A., Midmore, L., Kucuk, O., Lis, L.J., Westerman, M.P., Bras, W., Wolfe, D.H., Quinn, P.J., Qadri, S.B., Sterols stabilize the ripple phase-structure in dihexadecylphosphatidylcholine. Biochimica Et Biophysica Acta-Biomembranes 1233 (1995), 75–83.
59. Cyster, J.G., Dang, E.V., Reboldi, A., Yi, T., 25-Hydroxycholesterols in innate and adaptive immunity. Nat. Rev. Immunol. 14 (2014), 731–743.
60. Dasari, B., Prasanthi, J.R.P., Marwarha, G., Singh, B.B., Ghribi, O., The oxysterol 27-hydroxycholesterol increases beta-amyloid and oxidative stress in retinal pigment epithelial cells. BMC Ophthalmol., 10, 2010.
61. DuSell, C.D., Nelson, E.R., Wang, X.J., Abdo, J., Moedder, U.I., Umetani, M., Gesty-Palmer, D., Javitt, N.B., Khosla, S., McDonnell, D.P., The endogenous selective estrogen receptor modulator 27-Hydroxycholesterol is a negative regulator of bone homeostasis. Endocrinology 151 (2010), 3675–3685.
62. Dzeletovic, S., Breuer, O., Lund, E., Diczfalusy, U., Determination of cholesterol oxidation-products in human plasma by isotope-dilution mass-spectrometry. Anal. Biochem. 225 (1995), 73–80.
63. Eberlé, D., Hegarty, B., Bossard, P., Ferré, P., Foufelle, F., SREBP transcription factors: master regulators of lipid homeostasis. Biochimie 86 (2004), 839–848.
64. Edidin, M., The state of lipid rafts: from model membranes to cells. Annu. Rev. Biophys. Biomol. Struct. 32 (2003), 257–283.
65. Egli, U.H., Streuli, R.A., Dubler, E., Influence of oxygenated sterol compounds on phase-transitions in model membranes—a study by differential scanning calorimetry. Biochemistry 23 (1984), 148–152.
66. Epand, R.M., Bottega, R., Modulation of the phase-transition behavior of phosphatidylethanolamine by cholesterol and oxysterols. Biochemistry 26 (1987), 1820–1825.
67. Epand, R.M., Cholesterol and the interaction of proteins with membrane domains. Prog. Lipid Res. 45 (2006), 279–294.
68. Fakheri, R.J., Javitt, N.B., 27-Hydroxycholesterol, does it exist?: On the nomenclature and stereochemistry of 26-hydroxylated sterols. Steroids 77 (2012), 575–577.
69. Fruhwirth, G.O., Loidl, A., Hermetter, A., Oxidized phospholipids: from molecular properties to disease. Biochimica et Biophysica Acta (BBA) Molecular Basis of Disease 1772 (2007), 718–736.
70. Fuda, H., Javitt, N.B., Mitamura, K., Ikegawa, S., Strott, C.A., Oxysterols are substrates for cholesterol sulfotransferase. J. Lipid Res. 48 (2007), 1343–1352.
71. Gale, S.E., Westover, E.J., Dudley, N., Krishnan, K., Merlin, S., Scherrer, D.E., Han, X., Zhai, X., Brockman, H.L., Brown, R.E., Covey, D.F., Schaffer, J.E., Schlesinger, P., Ory, D.S., Side chain oxygenated cholesterol regulates cellular cholesterol homeostasis through direct sterol-Membrane interactions. J. Biol. Chem. 284 (2009), 1755–1764.
72. Gamba, P., Testa, G., Gargiulo, S., Staurenghi, E., Poli, G., Leonarduzzi, G., Oxidized cholesterol as the driving force behind the development of Alzheimer's disease. Front. Aging Neurosci., 7, 2015.
73. Gaus, K., Kritharides, L., Schmitz, G., Boettcher, A., Drobnik, W., Langmann, T., Quinn, C.M., Death, A., Dean, R.T., Jessup, W., Apolipoprotein A-1 interaction with plasma membrane lipid rafts controls cholesterol export from macrophages. FASEB J., 18, 2004, 574.
74. Gelissen, I.C., Rye, K.A., Brown, A.J., Dean, R.T., Jessup, W., Oxysterol efflux from macrophage foam cells: the essential role of acceptor phospholipid. J. Lipid Res. 40 (1999), 1636–1646.
75. Gill, S., Chow, R., Brown, A.J., Sterol regulators of cholesterol homeostasis and beyond: the oxysterol hypothesis revisited and revised. Prog. Lipid Res. 47 (2008), 391–404.
76. Goldstein, J.L., Ho, Y.K., Basu, S.K., Brown, M.S., Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc. Natl. Acad. Sci. 76 (1979), 333–337.
77. Goldstein, J.L., DeBose-Boyd, R.A., Brown, M.S., Protein sensors for membrane sterols. Cell 124 (2006), 35–46.
78. Graham, A., Allen, A.-M., Mitochondrial function and regulation of macrophage sterol metabolism and inflammatory responses. World Journal of Cardiology 7 (2015), 277–286.
79. Griffiths, W.J., Crick, P.J., Wang, Y.Q., Methods for oxysterol analysis: past, present and future. Biochem. Pharmacol. 86 (2013), 3–14.
80. Grivennikov, S.I., Greten, F.R., Karin, M., Immunity, inflammation, and cancer. Cell 140 (2010), 883–899.
81. Guardiola, F., Dutta, P.C., Codony, R., Savage, G.P., (eds.) Cholesterol and Phytosterol Oxidation Products: Analysis, Occurrence, and Biological Effects, 2002, AOCS Press, Champaign, Illinois (USA) 400 pages, ISBN 1-893997-34-0.
82. Hac-Wydro, K., Wydro, P., Flasinski, M., The comparison of zymosterol vs cholesterol membrane properties—the effect of zymosterol on lipid monolayers. Colloids and Surfaces B-Biointerfaces 123 (2014), 524–532.
83. Hac-Wydro, K., Weder, K., Mach, M., Flasinski, M., Wydro, P., The influence of cholesterol precursor – desmosterol – on artificial lipid membranes. Biochimica Et Biophysica Acta-Biomembranes 1848 (2015), 1639–1645.
84. Hannedouche, S., Zhang, J., Yi, T., Shen, W., Nguyen, D., Pereira, J.P., Guerini, D., Baumgarten, B.U., Roggo, S., Wen, B., Knochenmuss, R., Noel, S., Gessier, F., Kelly, L.M., Vanek, M., Laurent, S., Preuss, I., Miault, C., Christen, I., Karuna, R., Li, W., Koo, D.-I., Suply, T., Schmedt, C., Peters, E.C., Falchetto, R., Katopodis, A., Spanka, C., Roy, M.-O., Detheux, M., Chen, Y.A., Schultz, P.G., Cho, C.Y., Seuwen, K., Cyster, J.G., Sailer, A.W., Oxysterols direct immune cell migration via EBI2. Nature 475 (2011), 524–527.
85. Harikkhan, R., Holmes, R.P., Estimation of 26-hydroxycholesterol in serum by high-performance liquid-chromatography and its measurement in patients with atherosclerosis. J. Steroid Biochem. Mol. Biol. 36 (1990), 351–355.
86. Hayden, J.M., Brachova, L., Higgins, K., Obermiller, L., Sevanian, A., Khandrika, S., Reaven, P.D., Induction of monocyte differentiation and foam cell formation in vitro by 7-Ketocholesterol. J. Lipid Res. 43 (2002), 26–35.
87. Holmes, R.P., Yoss, N.L., 25-Hydroxysterols increase the permeability of liposomes to CA-2+ and other cations. Biochim. Biophys. Acta 770 (1984), 15–21.
88. Hulten, L.M., Lindmark, H., Diczfalusy, U., Bjorkhem, I., Ottosson, M., Liu, Y., Bondjers, G., Wiklund, O., Oxysterols present in atherosclerotic tissue decrease the expression of lipoprotein lipase messenger RNA in human monocyte-derived macrophages. J. Clin. Invest. 97 (1996), 461–468.
89. Ikonen, E., Jansen, M., Cellular sterol trafficking and metabolism: spotlight on structure. Curr. Opin. Cell Biol. 20 (2008), 371–377.
90. Ikonen, E., Cellular cholesterol trafficking and compartmentalization. Nat. Rev. Mol. Cell Biol. 9 (2008), 125–138.
91. Incardona, J.P., Eaton, S., Cholesterol in signal transduction. Curr. Opin. Cell Biol. 12 (2000), 193–203.
92. Indaram, M., Ma, W.X., Zhao, L., Fariss, R.N., Rodriguez, I.R., Wong, W.T., 7-Ketocholesterol increases retinal microglial migration, activation, and angiogenicity: a potential pathogenic mechanism underlying age-related macular degeneration. Sci. Rep., 5, 2015.
93. Infante, R.E., Abi-Mosleh, L., Radhakrishnan, A., Dale, J.D., Brown, M.S., Goldstein, J.L., Purified NPC1 protein—I. Binding of cholesterol and oxysterols to a 1278-amino acid membrane protein. J. Biol. Chem. 283 (2008), 1052–1063.
94. Ipsen, J.H., Karlstrom, G., Mouritsen, O.G., Wennerstrom, H., Zuckermann, M.J., Phase-equilibria in the phosphatidylcholine-cholesterol system. Biochim. Biophys. Acta 905 (1987), 162–172.
95. Javitt, N.B., Kok, E., Burstein, S., Cohen, B., Kutscher, J., 26-Hydroxycholesterol—identification and quantitation in human-serum. J. Biol. Chem. 256 (1981), 2644–2646.
96. Javitt, N.B., Oxysterols: novel biologic roles for the 21st century. Steroids 73 (2008), 149–157.
97. Javitt, N.B., Breast cancer and (25R)-26-hydroxycholesterol. Steroids 104 (2015), 61–64.
98. Jessup, W., Brown, A.J., Perspective—novel routes for metabolism of 7-ketocholesterol. Rejuvenation Res. 8 (2005), 9–12.
99. Jessup, W., Wilson, P., Gaus, K., Kritharides, L., Oxidized lipoproteins and macrophages. Vascul. Pharmacol. 38 (2002), 239–248.
100. Jessup, W., Gaus, K., Kritharides, L., Boettcher, A., Drobnik, W., Langmann, T., Schmitz, G., Death, A., Quinn, C.M., Dean, R.T., Apolipoprotein A-1 interaction with plasma membrane lipid rafts controls cholesterol export from macrophages. Atheroscler. Suppl., 4, 2003 69–69.
101. Joseph, S.B., Castrillo, A., Laffitte, B.A., Mangelsdorf, D.J., Tontonoz, P., Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nat. Med. 9 (2003), 213–219.
102. Jurkiewicz, P., Olżyńska, A., Cwiklik, L., Conte, E., Jungwirth, P., Megli, F.M., Hof, M., Biophysics of lipid bilayers containing oxidatively modified phospholipids: insights from fluorescence and EPR experiments and from MD simulations. Biochimica et Biophysica Acta (BBA) Biomembranes 1818 (2012), 2388–2402.
103. Jusakul, A., Yongvanit, P., Loilome, W., Namwat, N., Kuver, R., Mechanisms of oxysterol-induced carcinogenesis. Lipids in Health and Disease, 10, 2011, 44, 10.1186/1476-511X-10-44.
104. Kamal, M.A., Raghunathan, V.A., Effect of ring-substituted oxysterols on the phase behavior of dipalmitoylphosphatidylcholine membranes. European Biophysics Journal with Biophysics Letters 41 (2012), 891–900.
105. Kan, C.C., Yan, J.S., Bittman, R., Rates of spontaneous exchange of synthetic radiolabeled sterols between lipid vesicles. Biochemistry 31 (1992), 1866–1874.
106. Karilainen, T., Timr, Š., Vattulainen, I., Jungwirth, P., Oxidation of cholesterol does not alter significantly its uptake into high-Density lipoprotein particles. J. Phys. Chem. B 119 (2015), 4594–4600.
107. Karmakar, S., Raghunathan, V.A., Cholesterol-induced modulated phase in phospholipid membranes. Phys. Rev. Lett., 91, 2003.
108. Karmakar, S., Raghunathan, V.A., Structure of phospholipid-cholesterol membranes: an x-ray diffraction study. Phys. Rev. E, 71, 2005.
109. Kauffman, J.M., Westerman, P.W., Carey, M.C., Fluorocholesterols, in contrast to hydroxycholesterols, exhibit interfacial properties similar to cholesterol. J. Lipid Res. 41 (2000), 991–1003.
110. Keller, R.K., Arnold, T.P., Fliesler, S.J., Formation of 7-dehydrocholesterol-containing membrane rafts in vitro and in vivo, with relevance to the Smith-Lemli-Opitz syndrome. J. Lipid Res. 45 (2004), 347–355.
111. Khelashvili, G., Harries, D., How cholesterol tilt modulates the mechanical properties of saturated and unsaturated lipid membranes. J. Phys. Chem. B 117 (2013), 2411–2421.
112. Khelashvili, G., Harries, D., How sterol tilt regulates properties and organization of lipid membranes and membrane insertions. Chem. Phys. Lipids 169 (2013), 113–123.
113. Kim, D.H., Frangos, J.A., Effects of amyloid beta-peptides on the lysis tension of lipid bilayer vesicles containing oxysterols. Biophys. J. 95 (2008), 620–628.
114. Kim, S.-M., Kim, B.-Y., Eo, S.-K., Kim, C.-D., Kim, K., 27-Hydroxycholesterol up-regulates CD14 and predisposes monocytic cells to superproduction of CCL2 in response to lipopolysaccharide. Biochimica Et Biophysica Acta-Molecular Basis of Disease 1852 (2015), 442–450.
115. Kim, S.-M., Lee, C.W., Kim, B.-Y., Jung, Y.-S., Eo, S.-K., Park, Y.C., Kim, K., 27-Oxygenated cholesterol induces expression of CXCL8 in macrophages via NF-kappa B and CD88. Biochem. Biophys. Res. Commun. 463 (2015), 1152–1158.
116. Krause, M.R., Regen, S.L., The structural role of cholesterol in cell membranes: from condensed bilayers to lipid rafts. Acc. Chem. Res. 47 (2014), 3512–3521.
117. Krause, M.R., Wang, M., Mydock-McGrane, L., Covey, D.F., Tejada, E., Almeida, P.F., Regen, S.L., Eliminating the roughness in cholesterol's β-Face: does it matter?. Langmuir 30 (2014), 12114–12118.
118. Kreilaus, F., Spiro, A.S., McLean, C.A., Garner, B., Jenner, A.M., Evidence for altered cholesterol metabolism in Huntington's disease post mortem brain tissue. Neuropathol. Appl. Neurobiol., 2015, 12286, 10.1111/nan.12286.
119. Kučerka, N., Pencer, J., Nieh, M.-P., Katsaras, J., Influence of cholesterol on the bilayer properties of monounsaturated phosphatidylcholine unilamellar vesicles. Eur. Phys. J. E 23 (2007), 247–254.
120. Kudo, K., Emmons, G.T., Casserly, E.W., Via, D.P., Smith, L.C., Pyrek, J.S., Schroepfer, G.J., Inhibitors of sterol synthesis—chromatography of acetate derivatives of oxygenated sterols. J. Lipid Res. 30 (1989), 1097–1111.
121. Kulig, W., Tynkkynen, J., Javanainen, M., Manna, M., Rog, T., Vattulainen, I., Jungwirth, P., How well does cholesteryl hemisuccinate mimic cholesterol in saturated phospholipid bilayers?. J. Mol. Model., 20, 2014.
122. Kulig, W., Jurkiewicz, P., Olżyńska, A., Tynkkynen, J., Javanainen, M., Manna, M., Rog, T., Hof, M., Vattulainen, I., Jungwirth, P., Experimental determination and computational interpretation of biophysical properties of lipid bilayers enriched by cholesteryl hemisuccinate. Biochimica et Biophysica Acta (BBA) Biomembranes 1848 (2015), 422–432.
123. Kulig, W., Olzynska, A., Jurkiewicz, P., Kantola, A.M., Komulainen, S., Manna, M., Pourmousa, M., Vazdar, M., Cwiklik, L., Rog, T., Khelashvili, G., Harries, D., Telkki, V.V., Hof, M., Vattulainen, I., Jungwirth, P., Cholesterol under oxidative stress-how lipid membranes sense oxidation as cholesterol is being replaced by oxysterols. Free Radic. Biol. Med. 84 (2015), 30–41.
124. Kuroki, S., Okamoto, S., Naito, T., Oda, H., Nagase, S., Saka, H., Nawata, H., Yamashita, H., Chijiiwa, K., Tanaka, M., Serum 7-alpha-hydroxycholesterol as a new parameter of liver-function in patients with chronic liver-diseases. Hepatology 22 (1995), 1182–1187.
125. Kuwabara, P.E., Labouesse, M., The sterol-sensing domain: multiple families, a unique role?. Trends Genet. 18 (2002), 193–201.
126. Lange, Y., Steck, T.L., Cholesterol homeostasis and the escape tendency (activity) of plasma membrane cholesterol. Prog. Lipid Res. 47 (2008), 319–332.
127. Lange, Y., Ye, J., Strebel, F., Movement of 25-hydroxycholesterol from the plasma-membrane to the rough endoplasmic-reticulum in cultured hepatoma-cells. J. Lipid Res. 36 (1995), 1092–1097.
128. Lange, Y., Ye, J., Rigney, M., Steck, T.L., Regulation of endoplasmic reticulum cholesterol by plasma membrane cholesterol. J. Lipid Res. 40 (1999), 2264–2270.
129. Lange, Y., Ye, J., Steck, T.L., How cholesterol homeostasis is regulated by plasma membrane cholesterol in excess of phospholipids. Proc. Natl. Acad. Sci. U.S.A. 101 (2004), 11664–11667.
130. Lathe, R., Sapronova, A., Kotelevtsev, Y., Atherosclerosis and Alzheimer – diseases with a common cause? Inflammation, oxysterols, vasculature. BMC Geriatrics, 14, 2014, 36, 10.1186/1471-2318-14-36.
131. Lee, W.-R., Ishikawa, T., Umetani, M., The interaction between metabolism, cancer and cardiovascular disease, connected by 27-hydroxycholesterol. Clinical Lipidology 9 (2014), 617–624.
132. Lelong, I., Luu, B., Mersel, M., Rottem, S., Effect of 7β-hydroxycholesterol on growth and membrane composition of Mycoplasma capricolum. FEBS Lett. 232 (1988), 354–358.
133. Lemaire, S., Lizard, G., Monier, S., Miguet, C., Gueldry, S., Volot, F., Gambert, P., Néel, D., Different patterns of IL-1β secretion, adhesion molecule expression and apoptosis induction in human endothelial cells treated with 7α-, 7β-hydroxycholesterol, or 7-Ketocholesterol. FEBS Lett. 440 (1998), 434–439.
134. Lemaire-Ewing, S., Berthier, A., Royer, M.C., Logette, E., Corcos, L., Bouchot, A., Monier, S., Prunet, C., Raveneau, M., Rébé, C., Desrumaux, C., Lizard, G., Néel, D., 7β-Hydroxycholesterol and 25-hydroxycholesterol-induced interleukin-8 secretion involves a calcium-dependent activation of c-fos via the ERK1/2 signaling pathway in THP-1 cells: oxysterols-induced IL-8 secretion is calcium-dependent. Cell Biol. Toxicol. 25 (2009), 127–139.
135. Leonarduzzi, G., Sottero, B., Poli, G., Oxidized products of cholesterol: dietary and metabolic origin, and proatherosclerotic effects (review). J. Nutr. Biochem. 13 (2002), 700–710.
136. Leonarduzzi, G., Biasi, F., Chiarpotto, E., Poli, G., Trojan horse-like behavior of a biologically representative mixture of oxysterols. Mol. Aspects Med. 25 (2004), 155–167.
137. Leonarduzzi, G., Gargiulo, S., Gamba, P., Testa, G., Sottero, B., Rossin, D., Staurenghi, E., Poli, G., Modulation of cell signaling pathways by oxysterols in age-related human diseases. Free Radic. Biol. Med., 75, 2014 S5–S5.
138. Leoni, V., Caccia, C., Oxysterols as biomarkers in neurodegenerative diseases. Chem. Phys. Lipids 164 (2011), 515–524.
139. Leoni, V., Caccia, C., The impairment of cholesterol metabolism in Huntington disease. Biochimica Et Biophysica Acta-Molecular and Cell Biology of Lipids 1851 (2015), 1095–1105.
140. Leoni, V., Oxysterols as markers of neurological disease—a review. Scandinavian Journal of Clinical & Laboratory Investigation 69 (2009), 22–25.
141. Li, W., Dalen, H., Eaton, J.W., Yuan, X.M., Apoptotic death of inflammatory cells in human atheroma. Arteriosclerosis Thrombosis and Vascular Biology 21 (2001), 1124–1130.
142. Li, X.M., Momsen, M.M., Brockman, H.L., Brown, R.E., Sterol structure and sphingomyelin acyl chain length modulate lateral packing elasticity and detergent solubility in model membranes. Biophys. J. 85 (2003), 3788–3801.
143. Li, W., Hellsten, A., Xu, L.H., Zhuang, D.M., Jansson, K., Brunk, U.T., Yuan, X.M., Foam cell death induced by 7 beta-hydroxycholesterol is mediated by labile iron-driven oxidative injury: mechanisms underlying induction of ferritin in human atheroma. Free Radic. Biol. Med. 39 (2005), 864–875.
144. Lichtenberg, D., Goni, F.M., Heerklotz, H., Detergent-resistant membranes should not be identified with membrane rafts. Trends Biochem. Sci. 30 (2005), 430–436.
145. Lin, C.Y., Huo, C., Kuo, L.K., Hiipakka, R.A., Jones, R.B., Lin, H.P., Hung, Y.W., Su, L.C., Tseng, J.C., Kuo, Y.Y., Wang, Y.L., Fukui, Y., Kao, Y.H., Kokontis, J.M., Yeh, C.C., Chen, L.Y., Yang, S.D., Fu, H.H., Chen, Y.W., Tsai, K.K.C., Chang, J.Y., Chuu, C.P., Cholestane-3 beta, 5 alpha, 6 beta-triol suppresses proliferation, migration, and invasion of human prostate cancer cells. PLoS One, 8, 2013.
146. Liu, C., Yang, X.V., Wu, J., Kuei, C., Mani, N.S., Zhang, L., Yu, J., Sutton, S.W., Qin, N., Banie, H., Karlsson, L., Sun, S., Lovenberg, T.W., Oxysterols direct B-cell migration through EBI2. Nature 475 (2011), 519–523.
147. Liu, C., Yang, X.V., Wu, J., Kuei, C., Mani, N.S., Zhang, L., Yu, J., Sutton, S.W., Qin, N., Banie, H., Karlsson, L., Sun, S., Lovenberg, T.W., Oxysterols direct B-cell migration through EBI2. Nature 475 (2011), 519–523.
148. Lizard, G., Miguet, C., Besséde, G., Monier, S., Gueldry, S., Neel, D., Gambert, P., Impairment with various antioxidants of the loss of mitochondrial transmembrane potential and of the cytosolic release of cytochrome c occuring during 7-Ketocholesterol-induced apoptosis. Free Radic. Biol. Med. 28 (2000), 743–753.
149. Luchetti, F., Canonico, B., Cesarini, E., Betti, M., Galluzzi, L., Galli, L., Tippins, J., Zerbinati, C., Papa, S., Iuliano, L., 7-Ketocholesterol and 5,6-secosterol induce human endothelial cell dysfunction by differential mechanisms. Steroids 99 (2015), 204–211.
150. Lutjohann, D., Breuer, O., Ahlborg, G., Nennesmo, I., Siden, A., Diczfalusy, U., Bjorkhem, I., Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation. Proc. National Academy of Sciences of the United States of America 93 (1996), 9799–9804.
151. Mackrill, J.J., Oxysterols and calcium signal transduction. Chem. Phys. Lipids 164 (2011), 488–495.
152. Malgrange, B., Varela-Nieto, I., de Medina, P., Paillasse, M.R., Targeting cholesterol homeostasis to fight hearing loss: a new perspective. Front. Aging Neurosci., 7, 2015.
153. Mannock, D.A., Lewis, R.N.A.H., McMullen, T.P.W., McElhaney, R.N., The effect of variations in phospholipid and sterol structure on the nature of lipid-sterol interactions in lipid bilayer model membranes. Chem. Phys. Lipids 163 (2010), 403–448.
154. Martinez, G.V., Dykstra, E.M., Lope-Piedrafita, S., Job, C., Brown, M.F., NMR elastometry of fluid membranes in the mesoscopic regime. Phys. Rev. E, 66, 2002, 050902.
155. Martins, I.J., Berger, T., Sharman, M.J., Verdile, G., Fuller, S.J., Martins, R.N., Cholesterol metabolism and transport in the pathogenesis of Alzheimer's disease. J. Neurochem. 111 (2009), 1275–1308.
156. Marwarha, G., Ghribi, O., Does the oxysterol 27-hydroxycholesterol underlie Alzheimer's disease-Parkinson's disease overlap?. Exp. Gerontol. 68 (2015), 13–18.
157. Massey, J.B., Pownall, H.J., The polar nature of 7-Ketocholesterol determines its location within membrane domains and the kinetics of membrane micro solubilization by apolipoprotein A-I. Biochemistry 44 (2005), 10423–10433.
158. Massey, J.B., Pownall, H.J., Role of oxysterol structure on the microdomain-induced microsolubilization of phospholipid membranes by apolipoprotein A-I. Biochemistry 44 (2005), 14376–14384.
159. Massey, J.B., Pownall, H.J., Structures of biologically active oxysterols determine their differential effects on phospholipid membranes. Biochemistry 45 (2006), 10747–10758.
160. Massey, J.B., Membrane and protein interactions of oxysterols. Curr. Opin. Lipidol. 17 (2006), 296–301.
161. Maxfield, F.R., Tabas, I., Role of cholesterol and lipid organization in disease. Nature 438 (2005), 612–621.
162. Meaney, S., Bodin, K., Diczfalusy, U., Bjorkhem, I., On the rate of translocation in vitro and kinetics in vivo of the major oxysterols in human circulation: critical importance of the position of the oxygen function. J. Lipid Res. 43 (2002), 2130–2135.
163. Meszaros, P., Klappe, K., Hummel, I., Hoekstra, D., Kok, J.W., Function of MRP1/ABCC1 is not dependent on cholesterol or cholesterol-stabilized lipid rafts. Biochem. J 437 (2011), 483–491.
164. Meynier, A., Andre, A., Lherminier, J., Grandgirard, A., Demaison, L., Dietary oxysterols induce in vivo toxicity of coronary endothelial and smooth muscle cells. Eur. J. Nutr. 44 (2005), 393–405.
165. Miah, S., Zadeh, S.N.M., Yuan, X.-M., Li, W., Expression of Egr1 and p53 in human carotid plaques and apoptosis induced by 7-oxysterol or p53. Exp. Toxicol. Pathol. 65 (2013), 677–682.
166. Miguet, C., Monier, S., Bettaieb, A., Athias, A., Bessede, G., Laubriet, A., Lemaire, S., Neel, D., Gambert, P., Lizard, G., Ceramide generation occurring during 7 beta-hydroxycholesterol- and 7-Ketocholesterol-induced apoptosis is caspase independent and is not required to trigger cell death. Cell Death Differ. 8 (2001), 83–99.
167. Mintzer, E., Charles, G., Gordon, S., Interaction of two oxysterols, 7-Ketocholesterol and 25-hydroxycholesterol, with phosphatidylcholine and sphingomyelin in model membranes. Chem. Phys. Lipids 163 (2010), 586–593.
168. Mitomo, H., Chen, W.-H., Regen, S.L., Oxysterol-Induced rearrangement of the liquid-Ordered phase: a possible link to alzheimer's disease?. J. Amer. Chem. Soc. 131 (2009), 12354–12357.
169. Mol, M., deRijke, Y.B., Demacker, P.N.M., Stalenhoef, A.F.H., Plasma levels of lipid and cholesterol oxidation products and cytokines in diabetes mellitus and cigarette smoking: effects of vitamin E treatment. Atherosclerosis 129 (1997), 169–176.
170. Nelson, J.A., Steckbeck, S.R., Spencer, T.A., Biosynthesis of 24,25-epoxycholesterol from squalene 2,3-22,23-dioxide. Abstracts of Papers of the American Chemical Society 180 (1980), 278–ORGN.
171. Nelson, J.A., Steckbeck, S.R., Spencer, T.A., Biosynthesis of 24,25-epoxycholesterol from squalene 2,3-22,23-dioxide. J. Biol. Chem. 256 (1981), 1067–1068.
172. Neuvonen, M., Manna, M., Mokkila, S., Javanainen, M., Rog, T., Liu, Z., Bittman, R., Vattulainen, I., Ikonen, E., Enzymatic oxidation of cholesterol: properties and functional effects of cholestenone in cell membranes. PLoS One, 9, 2014.
173. Niemela, P.S., Castillo, S., Sysi-Aho, M., Oresic, M., Bioinformatics and computational methods for lipidomics. Journal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences 877 (2009), 2855–2862.
174. Noguchi, N., Numano, R., Kaneda, H., Niki, E., Oxidation of lipids in low density lipoprotein particles. Free Radic. Res. 29 (1998), 43–52.
175. Novelli, E., Zanardi, E., Ghiretti, G.P., Campanini, G., Dazzi, G., Madarena, G., Chizzolini, R., Lipid and cholesterol oxidation in frozen stored pork, salame Milano and mortadella. Meat Sci. 48 (1998), 29–40.
176. Nury, T., Zarrouk, A., Mackrill, J.J., Samadi, M., Durand, P., Riedinger, J.-M., Doria, M., Vejux, A., Limagne, E., Delmas, D., Prost, M., Moreau, T., Hammami, M., Delage-Mourroux, R., O'Brien, N.M., Lizard, G., Induction of oxiapoptophagy on 158N murine oligodendrocytes treated by 7-Ketocholesterol-, 7 beta-hydroxycholesterol-, or 24(S)-hydroxycholesterol: protective effects of alpha-tocopherol and docosahexaenoic acid. Steroids 99 (2015), 194–203 (DHA; C22:6 n-3).
177. O'Callaghan, Y.C., Woods, J.A., O'Brien, N.M., Characteristics of 7’-hydroxycholesterol-induced cell death in a human monocytic blood cell line, U937, and a human hepatoma cell line, HepG2. Toxicol. In Vitro 16 (2002), 245–251.
178. Ohvo-Rekila, H., Ramstedt, B., Leppimaki, P., Slotte, J.P., Cholesterol interactions with phospholipids in membranes. Prog. Lipid Res. 41 (2002), 66–97.
179. Olkkonen, V.M., Hynynen, R., Interactions of oxysterols with membranes and proteins. Mol. Aspects Med. 30 (2009), 123–133.
180. Olkkonen, V.M., Lehto, M., Oxysterols and oxysterol binding proteins: role in lipid metabolism and atherosclerosis. Ann. Med. 36 (2004), 562–572.
181. Olkkonen, V.M., Beaslas, O., Nissila, E., Oxysterols and their cellular effectors. Biomolecules 2 (2012), 76–103.
182. Olkkonen, V.M., Macrophage oxysterols and their binding proteins: roles in atherosclerosis. Curr. Opin. Lipidol. 23 (2012), 462–470.
183. Olsen, B.N., Schlesinger, P.H., Baker, N.A., Perturbations of membrane structure by cholesterol and cholesterol derivatives are determined by sterol orientation. J. Amer. Chem. Soc. 131 (2009), 4854–4865.
184. Olsen, B.N., Schlesinger, P.H., Ory, D.S., Baker, N.A., 25-Hydroxycholesterol increases the availability of cholesterol in phospholipid membranes. Biophys. J. 100 (2011), 948–956.
185. Olsen, B.N., Bielska, A.A., Lee, T., Daily, M.D., Covey, D.F., Schlesinger, P.H., Baker, N.A., Ory, D.S., The structural basis of cholesterol accessibility in membranes. Biophys. J., 106, 2014 509A–509A.
186. Otaegui-Arrazola, A., Menendez-Carreno, M., Ansorena, D., Astiasaran, I., Oxysterols: a world to explore. Food Chem. Toxicol. 48 (2010), 3289–3303.
187. Pöyry, S., Róg, T., Karttunen, M., Vattulainen, I., Significance of cholesterol methyl groups. J. Phys. Chem. B 112 (2008), 2922–2929.
188. Pandit, S.A., Scott, H.L., Multiscale simulations of heterogeneous model membranes. Biochimica Et Biophysica Acta-Biomembranes 1788 (2009), 136–148.
189. Panini, S.R., Sinensky, M.S., Mechanisms of oxysterol-induced apoptosis. Curr. Opin. Lipidol. 12 (2001), 529–533.
190. Parisio, G., Sperotto, M.M., Ferrarini, A., Flip-Flop of steroids in phospholipid bilayers: effects of the chemical structure on transbilayer diffusion. J. Amer. Chem. Soc. 134 (2012), 12198–12208.
191. Paul, R., Choudhury, A., Borah, A., Cholesterol—a putative endogenous contributor towards Parkinson's disease. Neurochem. Int. 90 (2015), 125–133.
192. Perlmutter, J.D., Sachs, J.N., Inhibiting lateral domain formation in lipid bilayers: simulations of alternative steroid headgroup chemistries. J. Amer. Chem. Soc., 131, 2009, 16362.
193. Perry, R.J., Ridgway, N.D., Oxysterol-binding protein and vesicle-associated membrane protein-associated protein are required for sterol-dependent activation of the ceramide transport protein. Mol. Biol. Cell 17 (2006), 2604–2616.
194. Phan, H.T.T., Hata, T., Morita, M., Yoda, T., Hamada, T., Vestergaard M. d.C. Takagi, M., The effect of oxysterols on the interaction of Alzheimer's amyloid beta with model membranes. Biochimica Et Biophysica Acta-Biomembranes 1828 (2013), 2487–2495.
195. Phillips, J.E., Geng, Y.J., Mason, R.P., 7-Ketocholesterol forms crystalline domains in model membranes and murine aortic smooth muscle cells. Atherosclerosis 159 (2001), 125–135.
196. Poli, G., Sottero, B., Gargiulo, S., Leonarduzzi, G., Cholesterol oxidation products in the vascular remodeling due to atherosclerosis. Mol. Aspects Med. 30 (2009), 180–189.
197. Porkkala-Sarataho, E., Salonen, J.T., Nyyssonen, K., Kaikkonen, J., Salonen, R., Ristonmaa, U., Diczfalusy, U., Brigelius-Flohe, R., Loft, S., Poulsen, H.E., Long-term effects of vitamin E, vitamin C, and combined supplementation on urinary 7-hydro-8-oxo-2′-deoxyguanosine, serum cholesterol oxidation products, and oxidation resistance of lipids in nondepleted men. Arteriosclerosis Thrombosis and Vascular Biology 20 (2000), 2087–2093.
198. Pulfer, M.K., Murphy, R.C., Formation of biologically active oxysterols during ozonolysis of cholesterol present in lung surfactant. J. Biol. Chem. 279 (2004), 26331–26338.
199. Róg, T., Vattulainen, I., Cholesterol, sphingolipids, and glycolipids: what do we know about their role in raft-like membranes?. Chem. Phys. Lipids 184 (2014), 82–104.
200. Radhakrishnan, A., Ikeda, Y., Kwon, H.J., Brown, M.S., Goldstein, J.L., Sterol-regulated transport of SREBPs from endoplasmic reticulum to Golgi: oxysterols block transport by binding to Insig. Proc. Natl. Acad. Sci. U.S.A. 104 (2007), 6511–6518.
201. Rantham Prabhakara, J.P., Feist, G., Thomasson, S., Thompson, A., Schommer, E., Ghribi, O., Differential effects of 24-hydroxycholesterol and 27-hydroxycholesterol on tyrosine hydroxylase and alpha-synuclein in human neuroblastoma SH-SY5Y cells. J. Neurochem. 107 (2008), 1722–1729.
202. Rheinstaedter, M.C., Mouritsen, O.G., Small-scale structure in fluid cholesterol-lipid bilayers. Current Opinion in Colloid & Interface Science 18 (2013), 440–447.
203. Rodriguez, I.R., Larrayoz, I.M., Cholesterol oxidation in the retina: implications of 7KCh formation in chronic inflammation and age-related macular degeneration. J. Lipid Res. 51 (2010), 2847–2862.
204. Rog, T., Pasenkiewicz-Gierula, M., Vattulainen, I., Karttunen, M., What happens if cholesterol is made smoother: importance of methyl substituents in cholesterol ring structure on phosphatidylcholine-sterol interaction. Biophys. J. 92 (2007), 3346–3357.
205. Rog, T., Stimson, L.M., Pasenkiewicz-Gierula, M., Vattulainen, I., Karttunen, M., Replacing the cholesterol hydroxyl group with the ketone group facilitates sterol flip-flop and promotes membrane fluidity. J. Phys. Chem. B 112 (2008), 1946–1952.
206. Rog, T., Vattulainen, I., Jansen, M., Ikonen, E., Karttunen, M., Comparison of cholesterol and its direct precursors along the biosynthetic pathway: effects of cholesterol, desmosterol and 7-dehydrocholesterol on saturated and unsaturated lipid bilayers. J. Chem. Phys., 129, 2008.
207. Rog, T., Pasenkiewicz-Gierula, M., Vattulainen, I., Karttunen, M., Ordering effects of cholesterol and its analogues. Biochimica Et Biophysica Acta-Biomembranes 1788 (2009), 97–121.
208. Rog, T., Poyry, S., Vattulainen, I., Building synthetic sterols Computationally—Unlocking the secrets of evolution?. Frontiers in bioengineering and biotechnology, 3, 2015 121–121.
209. Rooney, M., Tamuralis, W., Lis, L.J., Yachnin, S., Kucuk, O., Kauffman, J.W., The influence of oxygenated sterol compounds on dipalmitoylphosphatidylcholine bilayer structure and packing. Chem. Phys. Lipids 41 (1986), 81–92.
210. Rosenblat, M., Aviram, M., Oxysterol-induced activation of macrophage NADPH-oxidase enhances cell-mediated oxidation of LDL in the atherosclerotic apolipoprotein E deficient mouse: inhibitory role for vitamin E. Atherosclerosis 160 (2002), 69–80.
211. Roussi, S., Gosse, F., Aoude-Werner, D., Zhang, X., Geoffroy, P., Miesch, M., Marchioni, E., Raul, F., Perturbation of polyamine metabolism and its relation to cell death in human colon cancer cells treated by 7 beta-hydroxycholesterol and 7 beta-hydroxysitosterol. Int. J. Oncol. 29 (2006), 1549–1554.
212. Roussi, S., Gosse, F., Aoude-Werner, D., Zhang, X., Marchioni, E., Geoffroy, P., Miesch, M., Raul, F., Mitochondrial perturbation, oxidative stress and lysosomal destabilization are involved in 7 beta-hydroxysitosterol and 7 beta-hydroxycholesterol triggered apoptosis in human colon cancer cells. Apoptosis 12 (2007), 87–96.
213. Russell, D.W., Oxysterol biosynthetic enzymes. Biochimica et Biophysica Acta (BBA) Molecular and Cell Biology of Lipids 1529 (2000), 126–135.
214. Saito, Y., Yoshida, Y., Niki, E., Cholesterol is more susceptible to oxidation than linoleates in cultured cells under oxidative stress induced by selenium deficiency and free radicals. FEBS Lett. 581 (2007), 4349–4354.
215. Saldanha, T., Benassi, M.T., Bragagnolo, N., Fatty acid contents evolution and cholesterol oxides formation in Brazilian sardines (Sardinella brasiliensis) as a result of frozen storage followed by grilling. LWT Food Sci. Technol. 41 (2008), 1301–1309.
216. Salonen, J.T., Nyyssonen, K., Salonen, R., PorkkalaSarataho, E., Tuomainen, T.P., Diczfalusy, U., Bjorkhem, I., Lipoprotein oxidation and progression of carotid atherosclerosis. Circulation 95 (1997), 840–845.
217. Salvayre, R., Auge, N., Benoist, H., Negre-Salvayre, A., Oxidized low-density lipoprotein-induced apoptosis. Biochimica et Biophysica Acta (BBA) Molecular and Cell Biology of Lipids 1585 (2002), 213–221.
218. Schroepfer, G.J., Oxysterols: modulators of cholesterol metabolism and other processes. Physiol. Rev. 80 (2000), 361–554.
219. Sevanian, A., BittoloBon, G., Cazzolato, G., Hodis, H., Hwang, J., Zamburlini, A., Maiorino, M., Ursini, F., LDL(?) is a lipid hydroperoxide-enriched circulating lipoprotein. J. Lipid Res. 38 (1997), 419–428.
220. Sezgin, E., Levental, I., Grzybek, M., Schwarzmann, G., Mueller, V., Honigmann, A., Belov, V.N., Eggeling, C., Coskun, U., Simons, K., Schwille, P., Partitioning, diffusion, and ligand binding of raft lipid analogs in model and cellular plasma membranes. Biochimica Et Biophysica Acta-Biomembranes 1818 (2012), 1777–1784.
221. Shafaati, M., Marutle, A., Pettersson, H., Lovgren-Sandblom, A., Olin, M., Pikuleva, I., Winblad, B., Nordberg, A., Bjorkhem, I., Marked accumulation of 27-hydroxycholesterol in the brains of Alzheimer's patients with the Swedish APP 670/671 mutation. J. Lipid Res. 52 (2011), 1004–1010.
222. Shentu, T.P., Singh, D.K., Oh, M.J., Sun, S., Sadaat, L., Makino, A., Mazzone, T., Subbaiah, P.V., Cho, M., Levitan, I., The role of oxysterols in control of endothelial stiffness. J. Lipid Res. 53 (2012), 1348–1358.
223. Shibata, N., Glass, C.K., Macrophages, oxysterols and atherosclerosis. Circ. J. 74 (2010), 2045–2051.
224. Simon, S.A., McIntosh, T.J., Magid, A.D., Needham, D., Modulation of the interbilayer hydration pressure by the addition of dipoles at the hydrocarbon water interface. Biophys. J. 61 (1992), 786–799.
225. Simons, K., Ikonen, E., Cell biology—How cells handle cholesterol. Science 290 (2000), 1721–1726.
226. Simons, K., Sampaio, J.L., Membrane organization and lipid rafts. Cold Spring Harbor Perspect. Biol., 3, 2011.
227. Smaby, J.M., Brockman, H.L., Brown, R.E., Cholesterols interfacial interactions with sphingomyelins and phosphatidylcholines—hydrocarbon chain structure determines the magnitude of condensation. Biochemistry 33 (1994), 9135–9142.
228. Smondyrev, A.M., Berkowitz, M.L., Effects of oxygenated sterol on phospholipid bilayer properties: a molecular dynamics simulation. Chem. Phys. Lipids 112 (2001), 31–39.
229. Soccio, R.E., Adams, R.M., Maxwell, K.N., Breslow, J.L., Differential gene regulation of StarD4 and StarD5 cholesterol transfer proteins—activation of StarD4 by sterol regulatory element-binding protein-2 and StarD5 by endoplasmic reticulum stress. J. Biol. Chem. 280 (2005), 19410–19418.
230. Sottero, B., Gamba, P., Gargiulo, S., Leonarduzzi, G., Poli, G., Cholesterol oxidation products and disease: an emerging topic of interest in medicinal chemistry. Curr. Med. Chem. 16 (2009), 685–705.
231. Sottero, B., Gargiulo, S., Russo, I., Barale, C., Poli, G., Cavalot, F., Postprandial dysmetabolism and oxidative stress in type 2 diabetes: pathogenetic mechanisms and therapeutic strategies. Med. Res. Rev. 35 (2015), 968–1031.
232. Spann, N.J., Glass, C.K., Sterols and oxysterols in immune cell function. Nat. Immunol. 14 (2013), 893–900.
233. Staprans, I., Pan, X.M., Rapp, J.H., Feingold, K.R., Oxidized cholesterol in the diet is a source of oxidized lipoproteins in human serum. J. Lipid Res. 44 (2003), 705–715.
234. Staprans, I., Pan, X.M., Rapp, J.H., Feingold, K.R., The role of dietary oxidized cholesterol and oxidized fatty acids in the development of atherosclerosis. Molecular Nutrition & Food Research 49 (2005), 1075–1082.
235. Stocker, R., Keaney, J.F., Role of oxidative modifications in atherosclerosis. Physiol. Rev. 84 (2004), 1381–1478.
236. Stottrup, B.L., Keller, S.L., Phase behavior of lipid monolayers containing DPPC and cholesterol analogs. Biophys. J. 90 (2006), 3176–3183.
237. Stottrup, B.L., Hernandez-Balderrama, L.H., Kunz, J.C., Nguyen, A.H., Sonquist, B.J., Comparison of cholesterol and 25-Hydroxycholesterol in phase-Separated langmuir monolayers at the air-Water interface. J. Phys. Chem. B 118 (2014), 11231–11237.
238. Subczynski, W.K., Hyde, J.S., Kusumi, A., Oxygen permeability of phosphatidylcholine cholesterol membranes. Proc. Natl. Acad. Sci. U.S.A. 86 (1989), 4474–4478.
239. Subczynski, W.K., Wisniewska, A., Yin, J.J., Hyde, J.S., Kusumi, A., Hydrophobic barriers of lipid bilayer-membranes formed by reduction of water penetration by alkyl chain unsaturation and cholesterol. Biochemistry 33 (1994), 7670–7681.
240. Sun, L.-P., Seemann, J., Goldstein, J.L., Brown, M.S., Sterol-regulated transport of SREBPs from endoplasmic reticulum to Golgi: insig renders sorting signal in Scap inaccessible to COPII proteins. Proc. Natl. Acad. Sci. U.S.A. 104 (2007), 6519–6526.
241. Tall, A.R., Costet, P., Wang, N., Regulation and mechanisms of macrophage cholesterol efflux. J. Clin. Invest. 110 (2002), 899–904.
242. Telesford, D.-M., Verreault, D., Reick-Mitrisin, V., Allen, H.C., Reduced condensing and ordering effects by 7-Ketocholesterol and 5 beta,6 beta-Epoxycholesterol on DPPC monolayers. Langmuir 31 (2015), 9859–9869.
243. Teunissen, C.E., Floris, S., Sonke, M., Dijkstra, C.D., De Vries, H.E., Lutjohann, D., 24S-hydroxycholesterol in relation to disease manifestations of acute experimental autoimmune encephalomyelitis. J. Neurosci. Res. 85 (2007), 1499–1505.
244. Theunissen, J.J.H., Jackson, R.L., Kempen, H.J.M., Demel, R.A., Membrane properties of oxysterols. Interfacial orientation: influence on membrane permeability and redistribution between membranes. Biochimica et Biophysica Acta (BBA) Biomembranes 860 (1986), 66–74.
245. Tomono, S., Yasue, Y., Miyoshi, N., Ohshima, H., Cytotoxic effects of secosterols and their derivatives on several cultured cells. Biosci., Biotechnol., Biochem. 77 (2013), 651–653.
246. Tontonoz, P., Mangelsdorf, D.J., Liver X receptor signaling pathways in cardiovascular disease. Mol. Endocrinol. 17 (2003), 985–993.
247. Umetani, M., Domoto, H., Gormley, A.K., Yuhanna, I.S., Cummins, C.L., Javitt, N.B., Korach, K.S., Shaul, P.W., Mangelsdorf, D.J., 27-hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular effects of estrogen. Nat. Med. 13 (2007), 1185–1192.
248. Umetani, M., Ghosh, P., Ishikawa, T., Umetani, J., Ahmed, M., Mineo, C., Shaul, P.W., The cholesterol metabolite 27-Hydroxycholesterol promotes atherosclerosis via proinflammatory processes mediated by estrogen receptor alpha. Cell Metab. 20 (2014), 172–182.
249. Vejux, A., Lizard, G., Cytotoxic effects of oxysterols associated with human diseases: induction of cell death (apoptosis and/or oncosis), oxidative and inflammatory activities, and phospholipidosis. Mol. Aspects Med. 30 (2009), 153–170.
250. Verhagen, J.C.D., terBraake, P., Teunissen, J., vanGinkel, G., Sevanian, A., Physical effects of biologically formed cholesterol oxidation products on lipid membranes investigated with fluorescence depolarization spectroscopy and electron spin resonance. J. Lipid Res. 37 (1996), 1488–1502.
251. Verma, S.P., Philippot, J.R., Wallach, D.F.H., Chain-length dependent modification of lipid organization by low-levels of 25-hydroxycholesterol and 25-hydroxycholecalciferol—a laser raman-study. Biochemistry 22 (1983), 4587–4591.
252. Vestergaard, M.D.C., Yoda, T., Hamada, T., Akazawa, Y., Yoshida, Y., Takagi, M., The effect of oxycholesterols on thermo-induced membrane dynamics. Biochimica et Biophysica Acta-Biomembranes 1808 (2011), 2245–2251.
253. Vila, A., Korytowski, W., Girotti, A.W., Spontaneous intermembrane transfer of various cholesterol-derived hydroperoxide species: kinetic studies with model membranes and cells. Biochemistry 40 (2001), 14715–14726.
254. Vila, A., Levchenko, V.V., Korytowski, W., Girotti, A.W., Sterol carrier protein-2-facilitated intermembrane transfer of cholesterol- and phospholipid-derived hydroperoxides. Biochemistry 43 (2004), 12592–12605.
255. Vincent, M., Gallay, J., Steroid-lipid interactions in sonicated dipalmitoyl phosphatidyl choline vesicles: a steady-state and time-resolved fluorescence anisotropy study with all trans-1,6-diphenyl-1,3,5-hexatriene as probe. Biochem. Biophys. Res. Commun. 113 (1983), 799–810.
256. Vist, M.R., Davis, J.H., Phase-equilibria of cholesterol dipalmitoylphosphatidylcholine mixtures—h-2 nuclear magnetic-resonance and differential scanning calorimetry. Biochemistry 29 (1990), 451–464.
257. Vurusaner, B., Gamba, P., Testa, G., Gargiulo, S., Biasi, F., Zerbinati, C., Iuliano, L., Leonarduzzi, G., Basaga, H., Poli, G., Survival signaling elicited by 27-hydroxycholesterol through the combined modulation of cellular redox state and ERK/Akt phosphorylation. Free Radic. Biol. Med. 77 (2014), 376–385.
258. Wachtel, E., Bach, D., Epand, R.F., Tishbee, A., Epand, R.M., A product of ozonolysis of cholesterol alters the biophysical properties of phosphatidylethanolamine membranes. Biochemistry 45 (2006), 1345–1351.
259. Wamil, M., Andrew, R., Chapman, K.E., Street, J., Morton, N.M., Seckl, J.R., 7-Oxysterols modulate glucocorticoid activity in adipocytes through competition for 11β-hydroxysteroid dehydrogenase type. Endocrinology 149 (2008), 5909–5918.
260. Wang, J.W., Megha, London, E., Relationship between sterol/steroid structure and participation in ordered lipid domains (lipid rafts): Implications for lipid raft structure and function. Biochemistry 43 (2004), 1010–1018.
261. Wang, P.Y., Weng, F., Anderson, R.G.W., OSBP is a cholesterol-regrulated scaffolding protein in control of ERK1/2 activation. Science 307 (2005), 1472–1476.
262. Wang, Y., Kumar, N., Crumbley, C., Griffin, P.R., Burris, T.P., 2010. A second class of nuclear receptors for oxysterolsRegulation of RORα and RORγ activity by 24S-hydroxycholesterol (cerebrosterol). Biochimica et Biophysica Acta (BBA) Molecular and Cell Biology of Lipids 1801 (2010), 917–923.
263. Wenz, J.J., Barrantes, F.J., Steroid structural requirements for stabilizing or disrupting lipid domains. Biochemistry 42 (2003), 14267–14276.
264. Wenz, J.J., Molecular properties of steroids involved in their effects on the biophysical state of membranes. Biochimica Et Biophysica Acta-Biomembranes 1848 (2015), 2448–2459.
265. Wolf, G., The role of oxysterols in cholesterol homeostasis. Nutr. Rev. 57 (1999), 196–198.
266. Xiang, T.X., Anderson, B.D., Phospholipid surface-density determines the partitioning and permeability of acetic-acid in dmpc-cholesterol bilayers. J. Membr. Biol. 148 (1995), 157–167.
267. Xiang, T.X., Anderson, B.D., Phase structures of binary lipid bilayers as revealed by permeability of small molecules. Biochimica Et Biophysica Acta-Biomembranes 1370 (1998), 64–76.
268. Xiang, Y., Tang, J.J., Tao, W.Y., Cao, X.Z., Song, B.L., Zhong, J., Identification of cholesterol 25-Hydroxylase as a novel host restriction factor and a part of the primary innate immune responses against hepatitis C virus infection. J. Virol. 89 (2015), 6805–6816.
269. Xu, X.L., London, E., The effect of sterol structure on membrane lipid domains reveals how cholesterol can induce lipid domain formation. Biochemistry 39 (2000), 843–849.
270. Yao, Z.X., Han, Z., Xu, J., Greeson, J., Lecanu, L., Papadopoulos, V., 22R-Hydroxycholesterol induces differentiation of human NT2 precursor (Ntera2/D1 teratocarcinoma) cells. Neuroscience 148 (2007), 441–453.
271. Zarrouk, A., Vejux, A., Mackrill, J., O'Callaghan, Y., Hammami, M., O'Brien, N., Lizard, G., Involvement of oxysterols in age-related diseases and ageing processes. Ageing Res. Rev. 18 (2014), 148–162.
272. Zelcer, N., Tontonoz, P., Liver X receptors as integrators of metabolic and inflammatory signaling. J. Clin. Invest. 116 (2006), 607–614.
273. Zhang, Y., Yu, C.J., Liu, J., Spencer, T.A., Chang, C.C.Y., Chang, T.Y., Cholesterol is superior to 7-Ketocholesterol or 7 alpha-hydroxycholesterol as an allosteric activator for acyl-coenzyme A: cholesterol acyltransferase 1. J. Biol. Chem. 278 (2003), 11642–11647.
274. de Weille, J., Fabre, C., Bakalara, N., Oxysterols in cancer cell proliferation and death. Biochem. Pharmacol. 86 (2013), 154–160.
275. van Amerongen, A., Demel, R.A., Westerman, J., Wirtz, K.W.A., Transfer of cholesterol and oxysterol derivatives by the nonspecific lipid transfer protein (sterol carrier protein 2): a study on its mode of action. Biochimica et Biophysica Acta (BBA) − Lipids and Lipid Metabolism 1004 (1989), 36–43.
276. van Meer, G., Voelker, D.R., Feigenson, G.W., Membrane lipids: where they are and how they behave. Nat. Rev. Mol. Cell Biol. 9 (2008), 112–124.
277. van Reyk, D.M., Jessup, W., The macrophage in atherosclerosis: modulation of cell function by sterols. J. Leukoc. Biol. 66 (1999), 557–561.
278. van Reyk, D.M., Brown, A.J., Hult'en, L.M., Dean, R.T., Jessup, W., Oxysterols in biological systems: sources, metabolism and pathophysiological relevance. Redox Rep. 11 (2006), 255–262.
279. Zunin, P., Boggia, R., Evangelisti, F., Identification and quantification of cholesterol oxidation products in canned tuna. J. Am. Oil Chem. Soc. 78 (2001), 1037–1040.